|
๐
|
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
9 auth.
K. Hsu,
C. Keever-Taylor,
A. Wilton,
C. Pinto,
G. Heller,
K. Arkun,
...
R. O'reilly,
M. Horowitz,
B. Dupont
|
8 |
2005 |
8
๐
|
|
๐
|
Myeloablative Autologous StemโCell Transplantation for Severe Scleroderma
42 auth.
K. Sullivan,
E. Goldmuntz,
L. KeyesโElstein,
P. Mcsweeney,
A. Pinckney,
B. Welch,
M. Mayes,
R. Nash,
L. Crofford,
Barry E Eggleston,
Sharon M Castina,
Linda M. Griffith,
J. Goldstein,
Dennis Wallace,
O. Craciunescu,
...
D. Khanna,
R. Folz,
J. Goldin,
W. St Clair,
J. Seibold,
K. Phillips,
S. Mineishi,
R. Simms,
K. Ballen,
M. Wener,
G. Georges,
S. Heimfeld,
C. Hosing,
S. Forman,
S. Kafaja,
R. Silver,
Leroy. W. Griffing,
J. Storek,
S. Leclercq,
R. Brasington,
M. Csuka,
C. Bredeson,
C. Keever-Taylor,
R. Domsic,
B. Kahaleh,
T. Medsger,
D. Furst
|
8 |
2018 |
8
๐
|
|
๐
|
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
16 auth.
N. Shah,
Bryon D. Johnson,
D. Schneider,
F. Zhu,
A. Szabo,
C. Keever-Taylor,
W. Krueger,
A. Worden,
M. Kadan,
Sharon Yim,
...
Ashley M Cunningham,
M. Hamadani,
T. Fenske,
B. Dropuliฤ,
R. Orentas,
P. Hari
|
8 |
2020 |
8
๐
|
|
๐
|
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial
11 auth.
L. Burns,
D. Weisdorf,
T. Defor,
D. Vesole,
T. Repka,
B. Blazar,
...
S. Burger,
A. PanoskaltsisโMortari,
C. Keever-Taylor,
Mei-Jie Zhang,
J. Miller
|
7 |
2003 |
7
๐
|
|
๐
|
Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
20 auth.
R. Burt,
A. Traynor,
R. Pope,
J. Schroeder,
Bruce Cohen,
K. Karlin,
L. Lobeck,
C. Goolsby,
P. Rowlings,
Floyd Davis,
...
D. Stefoski,
C. Terry,
C. Keever-Taylor,
S. Rosen,
D. Vesole,
M. Fishman,
M. Brush,
Salim Mujias,
M. Villa,
W. Burns
|
7 |
1998 |
7
๐
|
|
๐
|
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.
12 auth.
S. Devine,
S. Carter,
R. Soiffer,
M. Pasquini,
P. Hari,
A. Stein,
...
H. Lazarus,
C. Linker,
E. Stadtmauer,
E. Alyea,
C. Keever-Taylor,
R. O'reilly
|
7 |
2011 |
7
๐
|
|
๐
|
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.
12 auth.
M. Pasquini,
S. Devine,
A. Mendizabal,
L. Baden,
J. Wingard,
H. Lazarus,
...
F. Appelbaum,
C. Keever-Taylor,
M. Horowitz,
S. Carter,
R. O'reilly,
R. Soiffer
|
7 |
2012 |
7
๐
|
|
๐
|
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients
16 auth.
R. Burt,
A. Traynor,
B. Cohen,
K. Karlin,
F. Davis,
D. Stefoski,
C. Terry,
L. Lobeck,
E. Russell,
C. Goolsby,
...
S. Rosen,
L. Gordon,
C. Keever-Taylor,
M. Brush,
M. Fishman,
W. Burns
|
6 |
1998 |
6
๐
|
|
๐ข
|
Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alt
7 auth.
W. Drobyski,
J. Klein,
N. Flomenberg,
D. Pietryga,
D. Vesole,
D. Margolis,
...
C. Keever-Taylor
|
6 |
2002 |
6
๐ข
|
|
๐ข
|
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
7 auth.
W. Drobyski,
M. Hessner,
J. Klein,
C. Kabler-Babbitt,
D. Vesole,
D. Margolis,
...
C. Keever-Taylor
|
6 |
1999 |
6
๐ข
|
|
๐ข
|
Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.
8 auth.
F. Zhu,
N. Shah,
Huiqing Xu,
D. Schneider,
R. Orentas,
B. Dropuliฤ,
...
P. Hari,
C. Keever-Taylor
|
6 |
2017 |
6
๐ข
|
